Five Prime Therapeutics, Inc. EBITDA 2013-2020 | FPRX
Five Prime Therapeutics, Inc. ebitda from 2013 to 2020. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Five Prime Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2020 | $-87 |
| 2019 | $-136 |
| 2018 | $-143 |
| 2017 | $-147 |
| 2016 | $-93 |
| 2015 | $291 |
| 2014 | $-35 |
| 2013 | $-27 |
| 2012 | $-26 |
| 2011 | $22 |
| 2010 | $-12 |
| Five Prime Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2020-12-31 | $-19 |
| 2020-09-30 | $-32 |
| 2020-06-30 | $-16 |
| 2020-03-31 | $-19 |
| 2019-12-31 | $-29 |
| 2019-09-30 | $-36 |
| 2019-06-30 | $-35 |
| 2019-03-31 | $-36 |
| 2018-12-31 | $-40 |
| 2018-09-30 | $-48 |
| 2018-06-30 | $-35 |
| 2018-03-31 | $-20 |
| 2017-12-31 | $-29 |
| 2017-09-30 | $-43 |
| 2017-06-30 | $-42 |
| 2017-03-31 | $-33 |
| 2016-12-31 | $-30 |
| 2016-09-30 | $-25 |
| 2016-06-30 | $-19 |
| 2016-03-31 | $-19 |
| 2015-12-31 | $335 |
| 2015-09-30 | $-23 |
| 2015-06-30 | $-11 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $-11 |
| 2014-09-30 | $-6 |
| 2014-06-30 | $-9 |
| 2014-03-31 | $-8 |
| 2013-12-31 | $-7 |
| 2013-09-30 | $-7 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-7 |
| 2012-09-30 | $-6 |
